insights_auto
Mengapa ANW naik 51,28%?
Pelajari Lebih Lanjutchevron_right
ANW:FRA
Immuron Ltd
€0,030
arrow_upward
+51,28%(+0,010) 1 HR
12 Okt, 08.05.52 GMT+2 · EUR
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk ANW...
Pembukaan
€0,03
Tinggi
€0,03
Rendah
€0,03
Kapitalisasi pasar
9,82 jt
Volume rata-rata
627,00
Volume
8,30 rb
Harga tinggi dalam 52 minggu terakhir
€0,04
Harga rendah dalam 52 minggu terakhir
€0,01
Jumlah karyawan
8
Pembukaan
€0,03
Tinggi
€0,03
Rendah
€0,03
Kapitalisasi pasar
9,82 jt
Volume rata-rata
627,00
Volume
8,30 rb
Harga tinggi dalam 52 minggu terakhir
€0,04
Harga rendah dalam 52 minggu terakhir
€0,01
Jumlah karyawan
8
Artikel berita
Dari sumber web dan partner berita
https://www.dars.gov.et/
·
1 minggu yang lalu
Immuron (IMRN) Slips 1.83% to $1.07 as Shares Drift Toward Lower Support - MA Cross Alert
Profil
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
Tentang Immuron Ltd
CEO-
Karyawan8
Didirikan1994
Kantor PusatBlackburn North, Victoria, Australia
Sektor-
Situsimmuron.com.au